Engineered IL-10 variants elicit potent immuno-modulatory activities at therapeutic low ligand doses
Claire Gorby(University of Dundee), Ignacio Moraga(University of Dundee)
Cited by 1
Related Papers
Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses
|Science Signaling|2020|83
Synthekines are surrogate cytokine and growth factor agonists that compel signaling through non-natural receptor dimers
|eLife|2017|69
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity
|eLife|2019|52
Structural insights into the assembly and activation of the IL‐27 signaling complex
|EMBO Reports|2022|33